The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The fear of cancer progression and recurrence in patients with pancreatic cancer.
 
Esther N. Pijnappel
No Relationships to Disclose
 
Willemieke P.M. Dijksterhuis
No Relationships to Disclose
 
Mirjam A.G. Sprangers
No Relationships to Disclose
 
Simone Augustinus
No Relationships to Disclose
 
Lonneke V van de Poll-Franse
No Relationships to Disclose
 
Judith de Vos-Geelen
Consulting or Advisory Role - Amgen; AstraZeneca; MSD; Pierre Fabre; SERVIER
Research Funding - SERVIER (Inst)
 
Hjalmar van Santvoort
No Relationships to Disclose
 
Ignace H.J.T. de Hingh
No Relationships to Disclose
 
I. Quintus Molenaar
No Relationships to Disclose
 
Olivier R.C. Busch
No Relationships to Disclose
 
Marc G.H. Besselink
No Relationships to Disclose
 
Johanna Wilmink
Consulting or Advisory Role - Celgene; SERVIER; Shire
Research Funding - Amgen; AstraZeneca; Celgene; Halozyme; Merck; Novartis; Pfizer; Roche; SERVIER
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly/ImClone; Nordic Group; Servier
Research Funding - Bayer Schering Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Nordic Group (Inst); Philips Healthcare (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca